Waters Corporation (NYSE:WAT) had its target price boosted by Barclays PLC from $188.00 to $193.00 in a research note issued to investors on Wednesday, October 25th. Barclays PLC currently has an equal weight rating on the medical instruments supplier’s stock.
Several other equities research analysts have also recently weighed in on the company. Deutsche Bank AG increased their price target on Waters Corporation from $199.00 to $200.00 and gave the company a hold rating in a research note on Wednesday, October 25th. Robert W. Baird increased their price target on Waters Corporation from $196.00 to $199.00 and gave the company an outperform rating in a research note on Wednesday, October 25th. Zacks Investment Research raised Waters Corporation from a hold rating to a buy rating and set a $211.00 price target for the company in a research note on Monday, October 23rd. Cleveland Research cut Waters Corporation from a buy rating to a neutral rating in a research note on Monday, October 9th. Finally, Morgan Stanley reaffirmed an underweight rating and set a $192.00 target price (up previously from $183.00) on shares of Waters Corporation in a research note on Friday, October 6th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $193.62.
Waters Corporation (NYSE WAT) traded down $1.76 during trading on Wednesday, reaching $193.21. The company’s stock had a trading volume of 383,100 shares, compared to its average volume of 523,562. The company has a quick ratio of 1.90, a current ratio of 6.16 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $15,506.55, a P/E ratio of 27.08, a PEG ratio of 2.83 and a beta of 0.83. Waters Corporation has a 1 year low of $133.35 and a 1 year high of $199.78.
Waters Corporation (NYSE:WAT) last issued its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.03. The company had revenue of $565.58 million during the quarter, compared to analysts’ expectations of $555.25 million. Waters Corporation had a return on equity of 23.61% and a net margin of 24.34%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.57 earnings per share. equities research analysts forecast that Waters Corporation will post 7.42 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Barclays PLC Raises Waters Corporation (NYSE:WAT) Price Target to $193.00” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/11/11/waters-corporation-wat-pt-raised-to-193-00.html.
In other news, SVP Rohit Khanna sold 18,400 shares of the firm’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $185.78, for a total value of $3,418,352.00. Following the transaction, the senior vice president now owns 22,477 shares in the company, valued at $4,175,777.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $197.95, for a total value of $2,375,400.00. Following the completion of the transaction, the senior vice president now owns 18,129 shares in the company, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,313 shares of company stock worth $11,120,642. Corporate insiders own 5.07% of the company’s stock.
Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Waters Corporation by 2.8% in the second quarter. Vanguard Group Inc. now owns 7,704,022 shares of the medical instruments supplier’s stock valued at $1,416,308,000 after purchasing an additional 206,262 shares in the last quarter. BlackRock Inc. lifted its holdings in Waters Corporation by 3.1% during the second quarter. BlackRock Inc. now owns 5,515,322 shares of the medical instruments supplier’s stock worth $1,013,936,000 after acquiring an additional 165,611 shares during the period. Fundsmith LLP lifted its holdings in Waters Corporation by 11.7% during the second quarter. Fundsmith LLP now owns 3,833,955 shares of the medical instruments supplier’s stock worth $704,834,000 after acquiring an additional 401,420 shares during the period. Janus Henderson Group PLC lifted its holdings in Waters Corporation by 20,670.6% during the second quarter. Janus Henderson Group PLC now owns 1,929,793 shares of the medical instruments supplier’s stock worth $354,773,000 after acquiring an additional 1,920,502 shares during the period. Finally, FMR LLC lifted its holdings in Waters Corporation by 7.4% during the second quarter. FMR LLC now owns 1,165,827 shares of the medical instruments supplier’s stock worth $214,326,000 after acquiring an additional 79,824 shares during the period. Institutional investors own 91.27% of the company’s stock.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.